Tag: lecanemab

The European Medicines Agency (EMA) has re-evaluated the anti-Alzheimer's drug lecanemab and has decided to authorize the product. The decision ...

Less than four months later, the European Medicines Agency recommends marketing authorization for lecanemab for the treatment of Alzheimer's disease. ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued, after months of ...